Viltepso side effects, by duration, gender and age (a phase IV clinical study of FDA data)

Summary:

Side effects are reported by people who take Viltepso (viltolarsen). Common side effects include adrenocortical insufficiency acute among males.

The phase IV clinical study is created by eHealthMe based on 75 reports from the FDA, and is updated regularly.

What is Viltepso?

Viltepso has active ingredients of viltolarsen. eHealthMe is studying from 75 Viltepso users. Check the latest studies of Viltepso.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

75 people who take Viltepso and have side effects are studied.

Viltepso side effects.

What are the common side effects of Viltepso, by gender? *:

female:

n/a

male:

  1. Adrenocortical insufficiency acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones)
  2. Catheter site cellulitis (infection of cells near catheter)
  3. Anaphylactic reaction (serious allergic reaction)
  4. Anxiety
  5. Chest pain
  6. Cough
  7. Cystatin c abnormal
  8. Cystatin c increased
  9. Drug hypersensitivity
  10. Fall

What are the common side effects of Viltepso, by age (0-1 to 60+) *:

0-1:

n/a

2-9:

  1. Dizziness
  2. Adverse event
  3. Anaphylactic reaction (serious allergic reaction)
  4. Heart rate increased
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Upper limb fracture

10-19:

  1. Adrenocortical insufficiency acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones)
  2. Catheter site cellulitis (infection of cells near catheter)
  3. Death
  4. Nausea (feeling of having an urge to vomit)
  5. Pyrexia (fever)
  6. Abdominal pain
  7. Anxiety
  8. Chest pain
  9. Cough
  10. Cystatin c abnormal

20-29:

  1. Pneumonia
  2. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the common side effects of Viltepso, by the time people have been on the drug (< 1 month to 10+ years)? *:

< 1 month:

  1. Upper respiratory tract infection
  2. Anaemia (lack of blood)
  3. Dizziness
  4. Anaphylactic reaction (serious allergic reaction)
  5. Cough
  6. Infusion site reaction
  7. Oedema (fluid collection in tissue)

1 - 6 months:

  1. Cystatin c abnormal

6 - 12 months:

  1. Death

1 - 2 years:

  1. Proteinuria (presence of protein in the urine)

2 - 5 years:

  1. Pneumonia

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Fracture
  2. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  3. Pyrexia (fever)
  4. Adrenocortical insufficiency acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones)
  5. Anxiety
  6. Cardiac failure
  7. Catheter site cellulitis (infection of cells near catheter)
  8. Chest pain
  9. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  10. Malaise (a feeling of general discomfort or uneasiness)

* Approximation only. Some reports may have incomplete information.

Do you take Viltepso?

- Personalize this study to your gender and age
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.



How the study uses the data?

The study is based on viltolarsen (the active ingredients of Viltepso) and Viltepso (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies are listed below in case you need more information:

Alternative drugs to, pros and cons of Viltepso:

All Viltepso side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: